If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
95.50    0.00 (0.00%)
Bid:
93.00
Ask:
98.00
Spread: 5.00 (5.376%)
Market Cap: £64.07m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding

31 Oct 2016 12:55

31 October 2016

ECO Animal Health Group plc ("ECO" or the "Company")

Director / PDMR Shareholding and Notification

The Company was notified on 28 October 2016 that on the same day the following director of the Company sold 140,000 ordinary shares of 5 pence each in the Company ("Ordinary Share"), at a price of £5.00 per Ordinary Share.

Director Position Holding pre-share sale Ordinary Shares sold Holding post-share sale Holding post-share sale % ISC
Peter Lawrence Chairman 9,938,477 140,000 9,798,477 15.1%

The Company’s issued ordinary share capital consists of 64,987,706 Ordinary Shares. Each Ordinary Share carries one vote. Accordingly, the number of Ordinary Shares with voting rights in issue is 64,987,706.

Enquiries

ECO Animal Health Group plc

Peter Lawrence, Executive Chairman 020 8336 6190

Marc Loomes, CEO 020 8447 8899

Spiro Financial

Anthony Spiro 020 8336 6196

Peel Hunt LLP (Nominated Adviser)

Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900

PDMR notification
1 Details of the Restricted Person/person closely associated with him or her
a) Name: Peter Lawrence
2 Reason for the notification
a) Position/Status Chairman
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: ECO Animal Health Group plc
b) LEI 01818170
4 Details of the transaction(s): section to be repeated for (i)each type of instrument: (ii) each type of transaction: (iii) each date: and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
b) Nature of transaction Sale of ordinary shares
c) Prices and volumes Sold 140,000 ordinary shares at £5.00
d) Aggregate information Volume 140,000 Ordinary Shares
Aggregate volume and price Price £5.00 per Ordinary Share
e) Date of transaction 28/10/2016 GMT
f) Place of the transaction London Stock Exchange (XLON), AIM market

View source version on businesswire.com: http://www.businesswire.com/news/home/20161031005608/en/

Copyright Business Wire 2016

Date   Source Headline
9th Oct 20247:00 amRNSIssue of Equity and TVR
1st Oct 20247:00 amRNSTrading Update
27th Sep 20242:21 pmRNSResult of AGM
30th Aug 20243:07 pmRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDeferred Share Option Award to Executive Directors
23rd Aug 20241:18 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSPosting of the Annual Report and Notice of AGM
12th Aug 20241:30 pmRNSBlock Listing Interim Review
15th Jul 20247:00 amRNSFinal Results
11th Jul 20249:30 amRNSNotice of Results
8th May 20247:00 amRNSRisk Profile Demonstrated for ECOVAXXIN MS
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.